Enhanced production of tumor necrosis factor-α and interleukin-6 due to prolonged response to lipopolysaccharide in human macrophages infected in vitro with human immunodeficiency virus type 1

Journal of Infectious Diseases

Volumn 179, Issue 4, 1999, Pages 832-842

  Bergamini, Alberto ^a   Faggioli, Emanuela ^b   Bolacchi, Francesca ^b   Gessani, Sandra ^b   Cappannoli, Luisa ^b   Uccella, Ilaria ^b   Demin, Flavio ^b   Capozzi, Marcella ^b   Cicconi, Rosella ^b   Placido, Roberta ^b   Vendetti, Silvia ^b   Colizzi, Giorgio Mancino Vittorio ^b   Rocchi, Giovanni ^b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

1 (NAPHTHOXYACETYL)HISTIDYL(5 AMINO 6 CYCLOHEXYL 3,4 DIHYDROXY 2 ISOPROPYLHEXANOYL)ISOLEUCINE N (2 PYRIDYLMETHYL)AMIDE; ANTIGEN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PROTEINASE; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE MARKER; FLOW CYTOMETRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; LYMPHOCYTE COUNT; MACROPHAGE ACTIVATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS INHIBITION; VIRUS LOAD;

EID: 0032957507     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314662     Document Type: Article

References (64)

1. Klatzmann D, Barrè-Sinoussi F, Nugeyre MT, et al. Selective tropism of lymphadenopathy-associated virus (LAV) for helper-inducer T lymphocytes. Science 1984; 225:59-63.
2. Popovic M, Sarngaradharan MG, Read E, Gallo RC. Detection, isolation and continuous production of cytopathic retroviruses (HTLV III) from patients from AIDS and pre-AIDS. Science 1984; 224:497-500.
3. Lahdevirta J, Maury CPJ, Teppo AM, Repo H. Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am J Med 1988; 85:289-91.
4. Breen EC, Rezai AR, Nakajima K, et al. Infection with HIV is associated with elevated IL-6 levels and production. J Immunol 1990; 144:480-4.
5. Duh EJ, Maury WJ, Folks TM, Fauci AS, Rabson AB. Tumor necrosis factor-α activates human immunodeficiency virus type I through induction of nuclear factor binding to the NF-kB sites in the long terminal repeat. Proc Natl Acad Sci USA 1989; 86:5974-8.
6. Poli G, Bressler P, Kinter A, et al Interleukin-6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor-α by transcriptional and post-transcriptional mechanism. J Exp Med 1990; 172:151-8.
7. Pluda JM, Venzon DJ, Tosato G, et al. Parameters affecting the development of non-Hodgkin's lymphoma in patients with severe human immunodeficiency virus infection receiving antiretroviral therapy. J Clin Oncol 1993; 11:1099-107.
8. Salahuddin SZ, Rose RM, Groopman JE, Markham PD, Gallo RC. Human T-lymphotropic virus type III infection of human alveolar macrophages. Blood 1986; 68:281-4.
9. Chayt KJ, Harper ME, Marselle LM, et al. Detection of HTLV-III RNA in kings of patients with AIDS and pulmonary involvement. JAMA 1986; 256:2356-9.
10. Armstrong JA, Horn P. Follicular dendritic cells and virus-like particles in AIDS-rclated lymphadenopathy. Lancet 1984; 2:370-6.
11. Gabuzda DH, Ho DD, de la Monte SM, Hirsch MS, Rota TR, Sobel RA. Immunohistochemical identification of HTLV-III antigen in brains of patients with AIDS. Ann Neurol 1986; 20:289-95.
12. Birx DL, Redfield RR, Tencer K, Fowler A, Burke DS, Tosato G. Induction of interleukin-6 during human immunodeficiency virus infection. Blood 1990; 76:2303-10.
13. Zembala M, Pryjma J, Plucienniczak A, et al. Interaction of HIV-1 gp120 molecule fragments with human monocytes: different requirements for tumor necrosis factor-a and IL-6 production. Clin Immunol Immunopathol 1995; 75:131-9.
14. Esser R, Glienke W, von Briesen H, Rubsamen-Waigmann H, Andreesen R. Differential regulation of proinflammatory and hematopoietic cytokines in human macrophages after infection with human immunodeficiency virus. Blood 1996; 88:3474-81.
15. Nakajima K, Martinez-Maza O, Hirano T, et al. Induction of IL-6 (B cell stimulatory factor-2/IFN-b2) production by HIV. J Immunol 1989; 142:531-6.
16. Molina JM, Scadden DT, Byrn R, Dinarello CA, Groopman JE. Production of tumor necrosis factor-α and interleukin-1β by monocytic cells infected with human immunodeficiency virus type 1 (HIV-1). J Clin Invest 1989; 84:733-7.
17. Perno CF, Bergamini A, Pesce CD, et al. Inhibition of the protcase of human immunodeficiency virus blocks replication and infectivity of the virus in chronically infected macrophages. J Infect Dis 1993; 168:1148-55.
18. Bergamini A, Capozzi M, Ghibelli L, et al. Cystamine potently suppresses in vitro HIV replication in acutely and chronically infected human cells. J Clin Invest 1994; 93:2251-7.
19. Andreoni M, Sarmati L, Parisi SG, Ercoli L, Rocchi G. Efficient and reproducible new semimicromethod for the detection and titration of HIV in human plasma. J Med Virol 1992; 38:207-13.
20. Karber G. Beitrag zur kollektiven Behandlung Pharmakologischer Reihenversuche. Arch Exp Pharmakol 1931; 162:480-3.
21. Placido R, Mancino G, Amendola A, et al. Apoptosis of human monocytes/ macrophages in Mycobacterium tuberculosis infection. J Pathol 1997; 181:31-8.
22. Young DA, Lowe LD, Clark CS. Comparison of the effects of IL-3, granulocyte-macrophage colony stimulating factor and macrophage colony stimulating factor in supporting monocyte differentiation inculture. Analysis of macrophage antibody-dependent cellular cytotoxicity. J Immunol 1990; 145:607-15.
23. Jung T, Schauer U, Heusser C, Neumann C, Rieger C. Detection of intracellular cytokines by flow cytometry. J Immunol Methods 1993; 159:197-207.
24. Jacobsen H, Mestan J, Mittnacht S. β-interferon subtype 1 induction by tumor necrosis factor. Mol Cell Biol 1989; 9:3037-42.
25. Chirgwin JM. Przybyla AE, McDonald RJ, Rytter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979; 18:5294-9.
26. Gessani S, Testa U, Varano B, et al. Enhanced production of LPS-induced cytokines during differentiation of human monocytes to macrophages. J Immunol 1993; 151:3758-66.
27. Bergamini A, Perno CF, Dini L, et al. Macrophage colony-stimulating factor enhances the susceptibility of macrophages to infection by human immunodeficiency virus and reduces the activity of compounds that inhibit virus binding. Blood 1994; 84:3405-12.
28. Molina JM, Schindler R, Ferriani R, et al. Production of cytokines by peripheral blood monocytes/macrophages infected with human immunodeficiency virus type 1 (HIV-1). J Infect Dis 1990; 161:888-93.
29. Kornbluth RS, Edgington TS. Tumor necrosis factor production by monocytes is a regulated event: induction of TNF-α mediated cellular cytotoxicity by endotoxin. J Immunol 1986; 137:2585-91.
30. Francis ML, Meltzer MS. Induction of IFN-α by HIV-1 in monocyte-enriched PBMC requires gp120-CD4 interaction but not virus replication. J Immunol 1993; 151:2208-16.
31. Bergamini A, Perno CF, Capozzi M, et al. A tetrazolium-based colorimetric assay for quantification of HIV-1 induced cytopathogenicity in monocyte-macrophages exposed to macrophage-colony stimulating factor. J Virol Methods 1992; 40:275-86.
32. Bergamini A, Dini L, Capozzi M, et al. Human immunodeficiency virus induced cell death in cytokine-treated macrophages can be prevented by compounds that inhibit late stages of viral replication. J Infect Dis 1996; 173:1367-78.
33. Jahr TG, Sundan A, Lichenstein HS, Espevik T. Influence of CD14, LBP and BPI in the monocyte response to LPS of different polysaccharide chain length. Scand J Immunol 1995; 42:119-27.
34. Dentener MA, Bazil V, Von Asmuth EJU, Ceska M, Buurman WA. Involvement of CD14 in lipopolysaccharide-induced tumor necrosis factor-α, IL-6 and IL-8 release by human monocytes and alveolar macrophages. J Immunol 1993; 150:2885-91.
35. Perera PY, Vogel SN, Detore GR, Haziot A, Goyert SM. CD14-dependent and CD14-independent signaling pathways in murine macrophages from normal and CD14 knockout mice stimulated with lipopolysaccharide or taxol. J Immunol 1997; 158:4422-9.
36. D'Addario M, Roulston A, Wainberg MA, Hiscott J. Coordinate enhancement ot cytokine gene expression in human immunodeficiency virus type 1 infected promonocytic cells. J Viral 1990; 64:6080-9.
37. Yamato K, el-Hajjaoui Z, Simon K, Koeffler HP. Modulation of interleukin-1β RNA in monocytic cells infected with human immunodeficiency virus-I. J Clin Invest 1990; 86:1109-14.
38. D'Addario M, Wainberg MA, Hiscott J. Activation of cytokine genes in HIV-1 infected myelomonoblastic cells by phorbol ester and tumor necrosis factor. J Immunol 1992; 148:1222-9.
39. Foli A, Saville MW, May LT, Webb DSA, Yarchoan R. Effects of human immunodeficiency virus and colony stimulating factors on the production of inlerleukin 6 and tumor necrosis factor α by monocyte/macrophages type 1 (HIV-1). AIDS Res Hum Retroviruses 1997; 13:829-39.
40. Chen BDM, Clark CR, Chou TH. Granulocyte/macrophage colony stimulating factor stimulates monocyte and tissue macrophage proliferation and enhances their responsiveness to macrophage colony-stimulating factor. Blood 1988; 71:997-1002.
41. Ampel NM, Wing EJ, Waheed A, Shadduck RK. Stimulatory effects of purified macrophage colony stimulating factor on murine resident peritoneal macrophage. Cell Immunol 1986; 97:344-56.
42. Becker S, Warren MK, Haskill S. Colony stimulating factor-induced monocyte survival and differentiation into macrophages in serum free cultures. J Immunol 1987; 139:3703-9.
43. Denis M. Tumor necrosis factor and granulocyte-macrophage colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium: killing effector mechanism depends on the generation of reactive nitrogen intermediates. J Leukoc Biol 1991; 49:380-7.
44. Suzu S, Motoyoshi K. Enhancing effect of human monocytic colony-stimulating factor on monocyte tumoricidal activity. Cancer Res 1989; 49: 5913-7.
45. Asakura E, Hanamura T, Umemura A, Yada K, Yamauchi T, Tanabe T. Effects of macrophage colony-stimulating factor (M-CSF) on lipopolysaccharide (LPS)-induced mediator production from monocyte in vitro. Immunobiology 1996; 195:300-13.
46. Furusawa S, Komatsu H, Saito K, Enokihara H, Hirose K, Shishido H. Effect of normal human serum on granulocyte colony formation by human bone marrow cells. J Lab Clin Med 1978; 91:377-86.
47. Chan SH, Metcalf D, Stanley ER. Stimulation and inhibition by normal human serum of colony formation in vitro by human bone marrow cells. Br J Haematol 1971; 20:329-41.
48. Gallo P, Pagni S, Giometto B, et al. Macrophage colony stimulating factor (M-CSF) in the cerebrospinal fluid. J Neuroimmunol 1990; 29:105-12.
49. Masood R, Lunardi-Iskandar Y, Moudgil T, et al. IL-10 inhibits HIV-1 replication and is induced by tat. Biophys Biochem Res Commun 1994; 202:374-83.
50. Borghi P, Fantuzzi L, Varano B, et al. Induction of interleukin 10 by human immunodeficiency virus type 1 and its gp-120 protein in human monocytes/macrophages. J Virol 1995; 69:1284-7.
51. Clouse KA, Cosentino LM, Weih KA, et al. The HIV-1 gp-120 envelope protein has the intrinsic capacity to stimulate monokine secretion. J Immunol 1991; 147:2892-901.
52. Miller AD, Curran T, Verma IM. c-fos protein can induce cellular transformation: a novel mechanism of activation of a cellular oncogene. Cell 1984; 36:51-60.
53. White K, Munro NH. Induction of ferritin subunit synthesis by iron is regulated at both the transcriptional and translational levels. J Biol Chem 1988; 263:8938-42.
54. Yen TJ, Machlin PS, Cleveland DW. Autoregolated instability of β-tubulin mRNAs by recognition of the nascent amino terminus of β-tubulin. Nature 1988; 334:580-5.
55. Sharma V, Knobloch TJ, Benjamin D. Differential expression of cytokine genes in HIV-1 tat transfected T and B cells. Biochem Biophys Res Commun 1995; 208:704-13.
56. Beutler B, Krochin N, Milsark V, Luedke C, Cerami A. Effect of γ interferon on cachectin expression by mononuclear phagocytes. J Exp Med 1986; 164:1791-9.
57. Seilhean D, Kobayashi K, He Y, et al. Tumor necrosis factor α, microglia and astrocytes in AIDS dementia complex. Acta Neuropathol (Berl) 1997; 93:508-17.
58. Wesselingh SL, Takahash K, Glass JD, McArthur JC, Griffin JW, Griffin DE. Cellular localization of tumor necrosis factor mRNA in neurological tissue from HIV-infected patients by combined reverse transcriptase/polymerase chain reaction in situ hybridization and immunohistochemistry. J Neuroimmunol 1997; 74:1-6.
59. Agostini C, Zambello R, Trentin L, et al. Expression of TNF receptors by T cells and membrane TNF-α by alveolar macrophages suggests a role in the regulation of the local immune response in the lung of HIV-1 infected patients. J Immunol 1995; 154:2928-38.
60. Agostini C, Sancetta R, Cerutti A, Semenzato G. Alveolar macrophages as a cell source of cytokine hyperproduction in HIV-related interstitial lung disease. J Leukoc Biol 1995; 58:495-500.
61. Brettle RP. Bacterial infections in HIV: the extent and nature of the problem. Int J STD AIDS 1997; 8:5-15
62. Moore DA, Gazzard BG, Nelson MR. Central venous line infections in AIDS. J Infect 1997; 34:35-40.
63. Stein TP, Koerner B, Schluter MD, et al. Weight loss, the gut and the inflammatory response in AIDS patients. Cytokine 1997; 9:143-7.
64. Heumunn D, Barras C, Severin A, Glauser MP, Tomasz A. Gram-positive cell walls stimulate synthesis of tumor necrosis factor α and interleukin 6 by human monocytes. Infect Immun 1994; 62:2715-21.